Clinical relevance of findings in trials of CBT for depression

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

Clinical relevance of findings in trials of CBT for depression. / Lepping, Peter; Whittington, R.; Sambhi, R.S. et al.
Yn: European Psychiatry, Cyfrol 45, 09.2017, t. 207-211.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Lepping, P, Whittington, R, Sambhi, RS, Lane, S, Poole, R, Leucht, S, Cuijpers, P, McGabe, R & Waheed, W 2017, 'Clinical relevance of findings in trials of CBT for depression', European Psychiatry, cyfrol. 45, tt. 207-211. https://doi.org/10.1016/j.eurpsy.2017.07.003

APA

Lepping, P., Whittington, R., Sambhi, R. S., Lane, S., Poole, R., Leucht, S., Cuijpers, P., McGabe, R., & Waheed, W. (2017). Clinical relevance of findings in trials of CBT for depression. European Psychiatry, 45, 207-211. https://doi.org/10.1016/j.eurpsy.2017.07.003

CBE

Lepping P, Whittington R, Sambhi RS, Lane S, Poole R, Leucht S, Cuijpers P, McGabe R, Waheed W. 2017. Clinical relevance of findings in trials of CBT for depression. European Psychiatry. 45:207-211. https://doi.org/10.1016/j.eurpsy.2017.07.003

MLA

VancouverVancouver

Lepping P, Whittington R, Sambhi RS, Lane S, Poole R, Leucht S et al. Clinical relevance of findings in trials of CBT for depression. European Psychiatry. 2017 Medi;45:207-211. Epub 2017 Gor 25. doi: 10.1016/j.eurpsy.2017.07.003

Author

Lepping, Peter ; Whittington, R. ; Sambhi, R.S. et al. / Clinical relevance of findings in trials of CBT for depression. Yn: European Psychiatry. 2017 ; Cyfrol 45. tt. 207-211.

RIS

TY - JOUR

T1 - Clinical relevance of findings in trials of CBT for depression

AU - Lepping, Peter

AU - Whittington, R.

AU - Sambhi, R.S.

AU - Lane, S.

AU - Poole, Robert

AU - Leucht, Stefan

AU - Cuijpers, P.

AU - McGabe, R.

AU - Waheed, W.

PY - 2017/9

Y1 - 2017/9

N2 - Cognitive behavioural therapy (CBT) is beneficial in depression. Symptom scores can be translated into Clinical Global Impression (CGI) scale scores to indicate clinical relevance. We aimed to assess the clinical relevance of findings of randomised controlled trials (RCTs) of CBT in depression. We identified RCTs of CBT that used the Hamilton Rating Scale for Depression (HAMD). HAMD scores were translated into Clinical Global Impression – Change scale (CGI-I) scores to measure clinical relevance. One hundred and seventy datasets from 82 studies were included. The mean percentage HAMD change for treatment arms was 53.66%, and 29.81% for control arms, a statistically significant difference. Combined active therapies showed the biggest improvement on CGI-I score, followed by CBT alone. All active treatments had better than expected HAMD percentage reduction and CGI-I scores. CBT has a clinically relevant effect in depression, with a notional CGI-I score of 2.2, indicating a significant clinical response. The non-specific or placebo effect of being in a psychotherapy trial was a 29% reduction of HAMD.

AB - Cognitive behavioural therapy (CBT) is beneficial in depression. Symptom scores can be translated into Clinical Global Impression (CGI) scale scores to indicate clinical relevance. We aimed to assess the clinical relevance of findings of randomised controlled trials (RCTs) of CBT in depression. We identified RCTs of CBT that used the Hamilton Rating Scale for Depression (HAMD). HAMD scores were translated into Clinical Global Impression – Change scale (CGI-I) scores to measure clinical relevance. One hundred and seventy datasets from 82 studies were included. The mean percentage HAMD change for treatment arms was 53.66%, and 29.81% for control arms, a statistically significant difference. Combined active therapies showed the biggest improvement on CGI-I score, followed by CBT alone. All active treatments had better than expected HAMD percentage reduction and CGI-I scores. CBT has a clinically relevant effect in depression, with a notional CGI-I score of 2.2, indicating a significant clinical response. The non-specific or placebo effect of being in a psychotherapy trial was a 29% reduction of HAMD.

U2 - 10.1016/j.eurpsy.2017.07.003

DO - 10.1016/j.eurpsy.2017.07.003

M3 - Article

VL - 45

SP - 207

EP - 211

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

ER -